Although our study also demonstrated that Il6 expression was unchanged in the liver during MASH pathogenesis, the contribution of IL-6 to the systemic insulin resistance associated with MASH should be further investigated. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.